Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × patritumab deruxtecan × Clear all

Phase

Phase 2 11 Phase 1/2 9 Phase 3 2 Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 61 Cyclophosphamide 57 pembrolizumab 39 fludarabine 38 Radiotherapy 30 Nivolumab 30 Biopsy 27 Metformin 23 Fluorodeoxyglucose F18 22 Bevacizumab 22 Specimen Handling 21 Temozolomide 18 Cisplatin 18 Radiosurgery 17 Carboplatin 16 Fluorouracil 15 Paclitaxel 14 Dexamethasone 14 Radiation 13 Gemcitabine 13 Etoposide 13 Rituximab 12 Positron Emission Tomography Computed Tomography 12 Letrozole 12 Irinotecan 12 gallium 68 PSMA-11 11 durvalumab 11 X-Rays 11 Surgical Procedures, Operative 11 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04610528 2023-06-23

TOT-HER3

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡